377 related articles for article (PubMed ID: 34522599)
1. Delivery strategies of amphotericin B for invasive fungal infections.
Wang X; Mohammad IS; Fan L; Zhao Z; Nurunnabi M; Sallam MA; Wu J; Chen Z; Yin L; He W
Acta Pharm Sin B; 2021 Aug; 11(8):2585-2604. PubMed ID: 34522599
[TBL] [Abstract][Full Text] [Related]
2. Small interfering RNA for cancer treatment: overcoming hurdles in delivery.
Charbe NB; Amnerkar ND; Ramesh B; Tambuwala MM; Bakshi HA; Aljabali AAA; Khadse SC; Satheeshkumar R; Satija S; Metha M; Chellappan DK; Shrivastava G; Gupta G; Negi P; Dua K; Zacconi FC
Acta Pharm Sin B; 2020 Nov; 10(11):2075-2109. PubMed ID: 33304780
[TBL] [Abstract][Full Text] [Related]
3. Application of flash nanoprecipitation to fabricate poorly water-soluble drug nanoparticles.
Tao J; Chow SF; Zheng Y
Acta Pharm Sin B; 2019 Jan; 9(1):4-18. PubMed ID: 30766774
[TBL] [Abstract][Full Text] [Related]
4. Carbon nanotubes for delivery of small molecule drugs.
Wong BS; Yoong SL; Jagusiak A; Panczyk T; Ho HK; Ang WH; Pastorin G
Adv Drug Deliv Rev; 2013 Dec; 65(15):1964-2015. PubMed ID: 23954402
[TBL] [Abstract][Full Text] [Related]
5. Assessment of in vitro antifungal efficacy and in vivo toxicity of Amphotericin B-loaded PLGA and PLGA-PEG blend nanoparticles.
Moraes Moreira Carraro TC; Altmeyer C; Maissar Khalil N; Mara Mainardes R
J Mycol Med; 2017 Dec; 27(4):519-529. PubMed ID: 28797532
[TBL] [Abstract][Full Text] [Related]
6. Optimization, stabilization, and characterization of amphotericin B loaded nanostructured lipid carriers for ocular drug delivery.
Lakhani P; Patil A; Wu KW; Sweeney C; Tripathi S; Avula B; Taskar P; Khan S; Majumdar S
Int J Pharm; 2019 Dec; 572():118771. PubMed ID: 31669555
[TBL] [Abstract][Full Text] [Related]
7. Development of thermosensitive hydrogel of Amphotericin-B and Lactoferrin combination-loaded PLGA-PEG-PEI nanoparticles for potential eradication of ocular fungal infections:
Elhabal SF; Ghaffar SA; Hager R; Elzohairy NA; Khalifa MM; Mohie PM; Gad RA; Omar NN; Elkomy MH; Khasawneh MA; Abdelaal N
Int J Pharm X; 2023 Dec; 5():100174. PubMed ID: 36908304
[TBL] [Abstract][Full Text] [Related]
8. Enhanced Antifungal Activity by Ab-Modified Amphotericin B-Loaded Nanoparticles Using a pH-Responsive Block Copolymer.
Tang X; Dai J; Xie J; Zhu Y; Zhu M; Wang Z; Xie C; Yao A; Liu T; Wang X; Chen L; Jiang Q; Wang S; Liang Y; Xu C
Nanoscale Res Lett; 2015 Dec; 10(1):969. PubMed ID: 26061446
[TBL] [Abstract][Full Text] [Related]
9. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable functional polycarbonate micelles for controlled release of amphotericin B.
Wang Y; Ke X; Voo ZX; Yap SSL; Yang C; Gao S; Liu S; Venkataraman S; Obuobi SAO; Khara JS; Yang YY; Ee PLR
Acta Biomater; 2016 Dec; 46():211-220. PubMed ID: 27686042
[TBL] [Abstract][Full Text] [Related]
11. Antifungal Activity of Chitosan-Coated Poly(lactic-co-glycolic) Acid Nanoparticles Containing Amphotericin B.
Ludwig DB; de Camargo LEA; Khalil NM; Auler ME; Mainardes RM
Mycopathologia; 2018 Aug; 183(4):659-668. PubMed ID: 29497926
[TBL] [Abstract][Full Text] [Related]
12. Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats.
Radwan MA; AlQuadeib BT; Šiller L; Wright MC; Horrocks B
Drug Deliv; 2017 Nov; 24(1):40-50. PubMed ID: 28155565
[TBL] [Abstract][Full Text] [Related]
13. Linolenic acid-modified methoxy poly (ethylene glycol)-oligochitosan conjugate micelles for encapsulation of amphotericin B.
Song Z; Wen Y; Deng P; Teng F; Zhou F; Xu H; Feng S; Zhu L; Feng R
Carbohydr Polym; 2019 Feb; 205():571-580. PubMed ID: 30446143
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antifungal effects of amphotericin B-TPGS-b-(PCL-ran-PGA) nanoparticles in vitro and in vivo.
Tang X; Zhu H; Sun L; Hou W; Cai S; Zhang R; Liu F
Int J Nanomedicine; 2014; 9():5403-13. PubMed ID: 25473279
[TBL] [Abstract][Full Text] [Related]
15. Amphotericin B in poly(lactic-co-glycolic acid) (PLGA) and dimercaptosuccinic acid (DMSA) nanoparticles against paracoccidioidomycosis.
Amaral AC; Bocca AL; Ribeiro AM; Nunes J; Peixoto DL; Simioni AR; Primo FL; Lacava ZG; Bentes R; Titze-de-Almeida R; Tedesco AC; Morais PC; Felipe MS
J Antimicrob Chemother; 2009 Mar; 63(3):526-33. PubMed ID: 19151037
[TBL] [Abstract][Full Text] [Related]
16. Low intensity ultrasound-mediated drug-loaded nanoparticles intravaginal drug delivery: an effective synergistic therapy scheme for treatment of vulvovaginal candidiasis.
Yang M; Cao Y; Zhang Z; Guo J; Hu C; Wang Z; Du Y
J Nanobiotechnology; 2023 Feb; 21(1):53. PubMed ID: 36782198
[TBL] [Abstract][Full Text] [Related]
17. Preparation, characterization, and evaluation of amphotericin B-loaded MPEG-PCL-g-PEI micelles for local treatment of oral
Zhou L; Zhang P; Chen Z; Cai S; Jing T; Fan H; Mo F; Zhang J; Lin R
Int J Nanomedicine; 2017; 12():4269-4283. PubMed ID: 28652732
[TBL] [Abstract][Full Text] [Related]
18. Charge-reversal nanoparticles: novel targeted drug delivery carriers.
Chen X; Liu L; Jiang C
Acta Pharm Sin B; 2016 Jul; 6(4):261-7. PubMed ID: 27471667
[TBL] [Abstract][Full Text] [Related]
19. Chitosan functionalized poly (ε-caprolactone) nanoparticles for amphotericin B delivery.
Vásquez Marcano RGDJ; Tominaga TT; Khalil NM; Pedroso LS; Mainardes RM
Carbohydr Polym; 2018 Dec; 202():345-354. PubMed ID: 30287009
[TBL] [Abstract][Full Text] [Related]
20. Amphotericin B aggregation inhibition with novel nanoparticles prepared with poly(epsilon-caprolactone)/poly(n,n-dimethylamino-2-ethyl methacrylate) diblock copolymer.
Shim YH; Kim YC; Lee HJ; Bougard F; Dubois P; Choi KC; Chung CW; Kang DH; Jeong YI
J Microbiol Biotechnol; 2011 Jan; 21(1):28-36. PubMed ID: 21301189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
